🇺🇸 FDA
Pipeline program

Cognitive Behavioral Therapy

5R01DA027650

Phase 3 other completed

Quick answer

Cognitive Behavioral Therapy for Stress Disorders, Post-Traumatic is a Phase 3 program (other) at BRIGHT MINDS BIOSCIENCES INC. with 1 ClinicalTrials.gov record(s).

Program details

Company
BRIGHT MINDS BIOSCIENCES INC.
Indication
Stress Disorders, Post-Traumatic
Phase
Phase 3
Modality
other
Status
completed

Clinical trials